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Abstract
Background: Health-system policy makers need timely access to synthesised research evidence to inform the policy-
making process. No efforts to address this need have been evaluated using an experimental quantitative design. We
developed an evidence service that draws inputs from Health Systems Evidence, which is a database of policy-relevant
systematic reviews. The reviews have been (a) categorised by topic and type of review; (b) coded by the last year
searches for studies were conducted and by the countries in which included studies were conducted; (c) rated for
quality; and (d) linked to available user-friendly summaries, scientific abstracts, and full-text reports. Our goal is to evaluate
whether a “full-serve” evidence service increases the use of synthesized research evidence by policy analysts and advisors
in the Ontario Ministry of Health and Long-Term Care (MOHLTC) as compared to a “self-serve” evidence service.
Methods/design: We will conduct a two-arm randomized controlled trial (RCT), along with a follow-up qualitative
process study in order to explore the findings in greater depth. For the RCT, all policy analysts and policy advisors (n =
168) in a single division of the MOHLTC will be invited to participate. Using a stratified randomized design, participants
will be randomized to receive either the “full-serve” evidence service (database access, monthly e-mail alerts, and full-text
article availability) or the “self-serve” evidence service (database access only). The trial duration will be ten months (two-
month baseline period, six-month intervention period, and two month cross-over period). The primary outcome will be
the mean number of site visits/month/user between baseline and the end of the intervention period. The secondary
outcome will be participants’ intention to use research evidence. For the qualitative study, 15 participants from each trial
arm (n = 30) will be purposively sampled. One-on-one semi-structured interviews will be conducted by telephone on
their views about and their experiences with the evidence service they received, how helpful it was in their work, why it
was helpful (or not helpful), what aspects were most and least helpful and why, and recommendations for next steps.
Discussion: To our knowledge, this will be the first RCT to evaluate the effects of an evidence service specifically
designed to support health-system policy makers in finding and using research evidence.
Trial registration: ClinicalTrials.gov: NCT01307228
Background
Health-system policy makers make important decisions
every day about the governance, financial, and delivery
arrangements within which programs, services, and
drugs are provided and about implementation strategies
[1]. The nature of their decisions will vary according to
the setting in which they work (e.g., federal, provincial,
o rl o c a lg o v e r n m e n t )a n dt h er o l et h e yp l a y( e.g.,p o l i t i -
cal staff, policy analyst, senior policy advisor, Assistant
Deputy Minister, or elected official), among other fac-
tors. Systematic reviews are increasingly seen as a key
source of information to inform these decisions [1].
Reduced bias and increased precision comprise the main
advantages of systematic reviews that address questions
about the effects of interventions [2]. Drawing on a sys-
tematic review that addresses any question constitutes a
more efficient use of time for busy policy makers
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any medium, provided the original work is properly cited.because the research literature has already been identi-
fied, selected, appraised, and synthesised in a systematic
and transparent way. Additionally, a systematic review
makes possible more constructive policy debates because
stakeholders can focus on the synthesis and its local
applicability rather than on which single study has
greater credibility [3].
In order to make informed decisions, health-system
policy makers need timely access to systematic reviews
that can be easily retrieved using terminology that is
understandable to them and that are presented in ways
that facilitate rapid scanning for relevance, recency of
searches for potentially relevant studies, the settings of
studies included in the review, and quality of the review
[3,4]. A systematic review of the factors that influence
the use of research in policy making identified timing/
timeliness as one of two factors that increased the pro-
spects for research use among health-system policy
makers [3,5]. However, when attempting to retrieve sys-
tematic reviews in a timely fashion, health-system policy
makers typically cannot search all of the potential
sources of systematic reviews. Moreover, policy makers
typically cannot search most sources of systematic
reviews, like The Cochrane Library, using terms with
which they are familiar. The number and searchability
of existing sources of systematic reviews become parti-
cularly frustrating when policy makers know there is
likely to be a review available on a topical issue. More-
over, search results typically do not highlight the types
of decision-relevant information that health-system pol-
icy makers are seeking [3,4].
One response to the similar types of issues faced by
clinical decision makers has been the development of
evidence services that provide regular email alerts about
newly identified research products and a searchable
database of these products[6]. However, no ‘full-serve’
evidence service currently exists to meet the needs of
health-system policy makers. Existing evidence services
that include health-system policy makers among their
target audiences, such as E-watch (http://kuuc.chair.ula-
val.ca/english/index.php) and CHAIN Canada (http://
www.epoc.uottawa.ca/CHAINCanada/), do not focus on
systematic reviews. Existing evidence services that focus
on high-quality studies (not just systematic reviews),
such as Evidence Updates (http://plus.mcmaster.ca/Evi-
denceUpdates/), do not target health-system policy
makers[6].
To address this gap, we developed a full-serve evi-
dence service for health-system policy makers. First, we
developed Health Systems Evidence, which contains
over 1,400 syntheses about governance, financial, and
delivery arrangements within health systems and about
implementation strategies relevant to health systems. By
syntheses we mean both systematic reviews and two
types of review-derived products, namely, policy briefs
and overviews of systematic reviews [7]. A policy brief
summarises how the findings from a number of sys-
tematic reviews pertain to a pressing problem, select
options for addressing the problem, and key implemen-
tation considerations, whereas an overview provides a
‘map’ of all available systematic reviews on a broad
health-system topic. The reviews have been (a) cate-
gorised by topic (i.e., by health-system arrangement or
implementation strategy), type of review (i.e.,p o l i c y
brief, overview of reviews, Cochrane systematic review,
systematic review, or systematic review protocol), and
type of question addressed (i.e., effectiveness, not effec-
tiveness, and ‘many’); (b) coded by the last year in which
searches for studies were conducted and by the coun-
tries in which included studies were conducted; (c)
rated for quality using the AMSTAR (A MeaSurement
Tool for the ‘Assessment of multiple systematic
Reviews’) instrument [8,9]; and (d) linked to available
user-friendly summaries, scientific abstracts, and full-
text reviews that are available free online [10].
Second, we identified systematic reviews in Health
Systems Evidence that are neither available free online
nor available through subscriptions held by the Ontario
Ministry of Health and Long-Term Care (MOHLTC)
and developed a mechanism to reimburse publishers for
full-text downloads of these reviews.
Third, we developed the format for monthly email
alerts, which (in tabular format) identifies new additions
to Health Systems Evidence and describes the type of
review, type of question addressed, health-system
arrangement or implementation strategy addressed, and
title of the review. A hypertext link for each review
enables policy makers to view the availability of (and
links to) user-friendly summaries, scientific abstracts,
and the full-text review. A hypertext link to the online
Health Systems Evidence webpage enables policy makers
to view additional information about these same recent
database additions, including the last year searched,
quality rating, the countries in which included studies
were conducted, and the complete citation. (Electronic
newsletter width restrictions precluded having all fields
presented in the monthly email alerts.)
Our goal is to evaluate whether (and how and why) a
full-serve evidence service increases the use of synthesised
research evidence by policy analysts and advisors in the
MOHLTC as compared to a ‘self-serve’ evidence service.
The full-serve evidence service comprises database access
(an effort to facilitate policy makers’ efforts to ‘pull’ in
research when they need it), monthly email alerts about
new additions to the database (a ‘push’ effort), and full-
text article availability (an additional effort to facilitate
pull). A systematic review found that simply providing
information (in the form of clinical-practice guidelines)
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ably confident that we have the potential to achieve an
increase in evidence use among health-system policy
makers. Moreover, the results of a cluster randomised trial
indicate that a full-serve evidence service increased practi-
cing clinicians’ utilisation of evidence-based information
from a digital library [12].
Methods/design
We will conduct this trial using a sequential explanatory
mixed-methods design, [13] beginning with the rando-
mised controlled trial (RCT) and then following up with
a qualitative process study to explore the RCT findings in
greater depth. For an initial two-month baseline period,
all participants will receive the self-serve evidence service.
For the following six-month period, the intervention
group will receive the full-serve evidence service and the
control group will continue to receive the self-serve evi-
dence service. For a final two-month period, both groups
will receive the full-serve evidence service. This protocol
received ethics approval from the Hamilton Health
Sciences/Faculty of Health Sciences Research Ethics
Board at McMaster University (project number 10-267).
RCT methods/design
Study population and recruitment
To recruit participants who deal with health-systems
issues on a regular basis, we will invite all policy analysts
and policy advisors from one purposively selected divi-
sion of the MOHLTC to participate in the RCT. All divi-
sion staff members similarly face a relatively new
expectation about obtaining training in finding and using
research evidence (in the form of an indicator in annual
performance reviews), as well as a new mandate for using
the Ministry’s ‘Research Evidence Tool’ for submissions
that support decision making at the Ministry Manage-
ment Committee and cabinet levels. Moreover, a trial
endorsement letter will be signed by the Assistant Deputy
Ministry responsible for this division. These contextual
developments precede the launch of the trial and help to
c r e a t eaf a v o u r a b l ec l i m a t ef o rt h eu s eo fr e s e a r c he v i -
dence among all potential trial participants.
Based on estimates provided to us in June 2009 by the
MOHLTC, there are approximately 49 policy analysts
(four are junior program and policy analysts) and 99
senior policy analysts in the division (n = 148). We do not
yet have an accurate estimate of the number of policy
advisors in the division; however, this group is likely to
include roughly 20 people and all of them are likely to be
senior policy advisors. By including all three levels of pol-
icy analysts and (if applicable) both levels of policy advi-
s o r s ,w ew i l lg a t h e re v i d e n c ef r o mad i v e r s eg r o u pt h a t
plays different roles in the policy-making process. For
example, a policy analyst might conduct the initial,
extensive ‘workup’ of an issue, whereas a senior policy
advisor might write a short briefing note for the Minister.
Selecting this sample of policy analysts and advisors
raises two applicability/generalisabilty issues. First, these
RCT participants will differ in whether and when they
received training on finding and using research evidence.
Two of us (JNL and MGW) delivered a series of five one-
day workshops for policy analysts and advisors at the
MOHLTC between July 2008 and March 2009 (i.e.,1 4t o
22 months before the trial will begin). We delivered five
additional one-day workshops, one half-day workshop,
and one half-day webinar for policy analysts and policy
advisors, as well as one 1.5-hour workshop for more
senior MOHLTC executives who set expectations for
these staff, between January and March 2010 (i.e.,t w ot o
four months before the trial will begin). Given the divi-
sion’s expectation about training, we can assume that
most RCT participants will have received the training.
However, newly hired policy analysts and advisors may
not have received the training, and others may not have
been able to participate due to scheduling conflicts; those
that have received the training will differ in the recency
of the training. Second, these RCT participants will differ
in their experience, which is somewhat related to their
position (i.e., level of policy analyst and level of policy
advisor). To address each of these applicability/generali-
sability issues, we will stratify the randomisation based
on past training and current position (see below).
Intervention and control arms
We will conduct a two-arm RCT with a full-serve evi-
dence service as the intervention arm and a self-serve
version as the control arm. Participants allocated to the
full-serve evidence service will receive the following:
￿ database (Health Systems Evidence) access (facilitat-
ing pull)
￿ monthly email alerts (push)
￿ full-text article availability (facilitating pull)
Participants allocated to the self-serve evidence service
will receive only database access, which is already pub-
licly available at http://www.healthsystemsevidence.org.
Randomisation
Participants will be randomised using a stratified design.
After completing the baseline questionnaire during the
two-month baseline period, participants will be allocated
to strata based on past workshop attendance (yes or no)
and their position (policy analyst, senior policy analyst,
or policy advisor). This two-layer stratification will pro-
duce six strata. Participants will be randomised after all
those who consent to participate in the trial have com-
pleted the baseline questionnaire. We will assign a
unique participant ID number to each participant and
then provide the list of IDs to a biostatistician external
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tion and keep a log to provide a clear audit trail. The
biostatistician will then communicate directly with a
knowledge broker external to the research team who
will be generating the email alerts and with the website
server administrator at McMaster University who will
be establishing which participants get access to which
evidence service. The participants and investigators will
be blinded to group assignment.
Outcomes
Measuring the impact of knowledge transfer and
exchange (KTE) interventions, such as the evidence ser-
vice proposed here, poses significant challenges [14]. The
ultimate goal of KTE interventions is typically to improve
health. However, there is a long chain of potential causal
relationships between an evidence service and improved
health. For instance, the evidence service may influence
the use of research evidence in different stages of the pol-
icy-making process, which in turn may influence deci-
sions made by patients and healthcare providers (e.g.,
healthcare professionals, teams, and institutions), which
may in turn influence whether cost-effective programs,
services, and drugs get to the patients who need them
a n dh a v et h e i rd e s i r e di m p a c t s ,a n dw h i c hi nt u r nm a y
translate into improved health [15]. Moreover, even the
first relationship in this long chain is complicated by the
competing influences on the policy-making process, such
as institutional constraints within a political system, sta-
keholder pressure campaigns, values and beliefs held by
key decision makers, and external factors such as the
state of the economy [16-18]. Similar challenges arise
when assessing the impact of KTE interventions, such as
guideline-dissemination strategies, on clinical practice
and on health [19-21].
Given these challenges, our primary and secondary
outcomes for the trial are proxy measures for the use of
research evidence in policy making. The primary out-
come will be a measure of utilisation that is similar to
the one used in a trial of the McMaster Premium Litera-
ture Updating Service (PLUS) [12]. Specifically, we will
track the mean number of site visits/month/participant
across trial groups during each period, that is, the base-
line period, intervention period, and crossover period.
We will also provide related descriptive measures such
as the proportion of users per month in each of the full-
serve and self-serve groups; the frequency with which
the full monthly update page, systematic review records,
and the more detailed documentation for each review
(e.g., user-friendly summaries, scientific abstracts, and
full-text reports) are accessed; the mean number of min-
utes per month that participants use the database (with
a ‘time out’ set at 60 minutes); and the number of times
the monthly email alerts are forwarded.
Health Systems Evidence will be hosted on a secure
server at McMaster University and will require a user
login that will be used to accurately track their usage of
the database. A user login is necessary because indivi-
duals from the MOHLTC do not have a consistent IP
address when accessing external websites, which would
preclude the collection of utilisation data if the site were
hosted without requiring users to login. In addition,
requiring user login will partially protect against con-
tamination of the control group. However, we cannot
rule out the possibility that individuals in the interven-
tion arm of the study will forward monthly email alerts
and full-text systematic reviews that are available only
by subscription to individuals in the control arm; how-
ever, we will collect data about alert forwarding.
For the secondary outcome, we will use a survey based
upon the theory of planned behaviour to measure parti-
cipants’ intention to use research evidence. The theory
of planned behaviour is a model of how human action
is guided [22,23], and it consists of three variables–atti-
tudes (i.e., beliefs and judgments), subjective norms (i.e.,
normative beliefs and judgments about those beliefs),
and perceived behavioural control (i.e.,t h ep e r c e i v e d
ability to enact the behaviour)–that shape the behaviour
intentions of people, which is in turn a strong predictor
of future behaviour [23-25]. In Figure 1, we outline lin-
kages among the intervention, contextual developments
(described above), and theory of planned behaviour con-
structs and measures.
The theory of planned behaviour has been extensively
used and tested in the fields of psychology and health-
care. Systematic reviews conducted in the psychology
field have demonstrated that the theory explains about
39% of the variance in intention and about 27% of the
variance in behaviour [24,25]. A number of studies have
demonstrated the feasibility of producing valid and reli-
able measures of key theory of planned behaviour con-
structs for use with healthcare professionals [26-28]. A
systematic review suggests that the proportion of the var-
iance in healthcare professionals’ behaviour explained by
intention was similar in magnitude to that found in the
broader literature [29]. This successful transfer of the
theory from individuals (as studied by psychologists) to
healthcare professionals involved in an agency relation-
ship with their patients (as studied by health-services
researchers) bodes well for its further transfer to policy
analysts and advisors involved in an agency relationship
with Ministers and other senior officials.
Using a manual to support health researchers who want
to construct measures based on the theory [23], we devel-
oped and sought preliminary feedback on a data collection
instrument by first assessing face validity through inter-
views with key informants and then pilot testing it with 28
policy makers and researchers from 20 low-middle income
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intervention [30]. In addition, Boyko et al. (2010) found
moderate test-retest reliability of the instrument using
generalisability theory (G = 0.50) [31] when scores from a
sample of 37 health-system policy makers, managers, pro-
fessionals, citizens/consumers, and researchers participat-
ing in stakeholder dialogues convened by the McMaster
Health Forum were generalised across a single administra-
tion, and even stronger reliability (G =0 . 9 )w h e ns c o r e s
were generalised across the average of two administrations
of the tool [30]. In the reliability assessment by Boyko et
al. (2010), the first administration of the tool immediately
followed a McMaster Health Forum stakeholder dialogue,
which may have promoted enthusiasm for using research
evidence among participants. This likely produced higher
measures of intention on the first administration of the
tool as compared to the second, resulting in the lower G
score. Given that we won’t be administering the tool in a
similar atmosphere of enthusiasm for using research evi-
dence, we are confident in the level of reliability of the
tool without two administrations at both baseline and fol-
low-up. We modified the instrument by adding a question
to measure the perceived usefulness of the intervention, as
well as questions about participant characteristics.
We will administer the instrument during the baseline
period, as well as at the end of the six-month intervention
period, through a brief online survey that takes approxi-
mately 10 minutes to complete. We will use unique identi-
fiers for each participant to ensure their responses to the
previous survey are linked for calculations of before-and-
after changes in their intention to use research evidence.
We will follow up with participants who do not complete
the survey once per week for three weeks to minimise the
number of participants lost to follow-up.
Data management and analysis
Data will be entered into SPSS 16.0 (IBM Corporation,
Somers, NY) after all data collection has been completed.
Analyses will be conducted by two members of the research
team (SH and MGW), and during the analysis, neither they
nor other study investigators will have access to the key
linking the participants to their unique identifiers.
We will treat both outcome measures as continuous
variables and analyse the change in these measures over
time using a two-way mixed-effects linear repeated-mea-
sures analysis of variance (ANOVA), with the interaction
of intervention by time as the main feature of interest. In
addition, we will control for four variables–past workshop
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x Mandatinguseofthe‘Research
EvidenceTool’forsubmissionsthat
supportdecisionmaking
x Trialendorsementletterfromsenior
official
Interventionelement1
x Emailalerts(push)
Interventionelement2
x FullͲtextarticleavailability
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Figure 1 Linkages among the intervention, contextual developments, and theory of planned behaviour constructs.
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or senior policy advisor), branch within the division (of
which there are six), and number of years working at the
MOHLTC–using analysis of covariance. Given the likeli-
hood that the distribution of the outcomes will be skewed,
we will transform the data where necessary and possible,
which may include adjusting the time period for which we
calculate the mean number of site visits/participant (e.g.,
calculating the mean over two months) if there are insuffi-
cient data for analysis. Moreover, as part of a secondary
analysis, we will assess whether there is an interaction
between each of these variables (entered as a fixed factor)
and the outcome measures. We will also qualitatively
compare the number of participants in the intervention
and control groups that do not complete the follow-up
survey and assess whether their baseline characteristics
can help to explain their loss to follow-up.
For all analyses, we will use the intention-to-treat
principle and report 95% confidence intervals; p values
equal to or less than .05 (two-tailed) will be considered
significant. For the primary outcome measure (mean
number of site visits/month/participant), missing data
a r ei r r e l e v a n tb e c a u s ei ti sanaturalistic measure. For
the secondary outcome measure (obtained through the
survey), missing data can be taken into account through
the use of a mixed-effects model.
Statistical precision
Given a fixed sample size of at least 148 policy analysts
and advisors in the division, a sample-size calculation is
not relevant. Instead, we have calculated the level of sta-
tistical precision that we can expect given our fixed
sample size. We had no mechanism to estimate the
intraclass correlation coefficient (ICC) for measurements
of the primary outcome for individuals over time.
Therefore, we calculated estimates of statistical precision
for ICCs of .2, .3, .5, .7, and .8 based on a six-month
trial period with 80% power; an estimated standard
deviation of 1.0; significance of .05; and 74 participants
per study group (total n = 148, which does not include
the as yet undefined number of senior policy advisors).
Assuming the primary outcome data will be collected
from all 148 participants at baseline and at six follow-up
points (one per month), the time-averaged detectable
difference (in standard deviation units) between the two
groups is at best 0.27 (ICC = .2), which increases with
successively greater ICCs to 0.30 (ICC = .3), 0.35 (ICC =
.5), 0.40 (ICC = .7), and 0.42 (ICC = .8).
Qualitative study methods/design
Given that this is the first RCT evaluating a KTE inter-
vention for health-system policy makers (at least to our
knowledge) and given the inherent limitations associated
with measuring research use as an outcome, we will
conduct a qualitative process study after the completion
of the trial to explore the RCT findings in greater depth.
The qualitative study will explore how and why the evi-
dence service worked (or didn’t work), including the
role of past workshop attendance and position and the
degree of contamination between the intervention and
control groups.
Sample
We will use a mixed-method sequential nested sampling
procedure, whereby a larger sample is analysed in one
study (RCT) and a subset of the larger sample is
selected for further inquiry in the second study [32].
Specifically, 15 participants from each trial arm (n = 30)
will be purposively sampled [33,34]. Our sampling cri-
teria include RCT arm (i.e., full-serve or self-serve evi-
dence service), outcomes, past workshop attendance,
position, branch within the division, and number of
years working at the MOHLTC. We have assumed a
70% response rate (in keeping with our past experience
with conducting qualitative studies involving health-sys-
tem policy makers), which means that we should sample
approximately 40 policy analysts and advisors in order
to achieve a sample size of 30.
Data collection
One-on-one semistructured interviews will be conducted
either by telephone or in person (where possible) on
participants’ views about and experiences with the evi-
dence service, including whether and how they used it
(and the degree of ‘contamination’ between the two
arms of the RCT, if any) and why, whether and how it
was helpful in their work and why, what aspects were
most and least helpful and why, and recommendations
for next steps. Potential explanatory factors (for which
we will probe) include past workshop attendance, posi-
tion, branch within the division, and number of years
working at the MOHLTC.
Data management and analysis
We will tape and transcribe all interviews, use NVivo 8
(QSR International, Cambridge, MA) for data manage-
ment, and use a constant comparative method for analy-
sis [35-37]. Specifically, two reviewers will identify
themes emerging from each successive wave of four to
five interviews and iteratively refine the interview guide
and emerging themes until we reach data saturation.
This strategy will allow the reviewers to develop and
refine codes and broader themes in NVivo 8 that reflect
the emerging and increasing levels of nuance that result
from the continuous checks that are involved in the con-
stant comparative method [35,37]. The same reviewers
will then apply the final analytic framework to all of the
interview transcripts and conduct member checking once
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summary of what we learned from the interviews and
invite comment on it).
Discussion
To our knowledge, this will be the first RCT to evaluate
the effects of an evidence service specifically designed to
support health-system policy makers in finding and using
research evidence. While there have been a number of
strategies developed to both support the production of
policy-relevant research evidence and the identification
and use of research evidence by health-system policy
makers [1,38], rigorous evaluations of the effects of these
strategies remains a critical gap in the KTE literature
[38,39]. This study will begin to address this gap by pro-
viding a rigorous evaluation of the effects of a KTE inter-
vention for policy makers and by examining how and
why the intervention succeeds or fails. In addition, this
trial will contribute to an emerging evidence base about
similarities and differences in ‘what works’ in KTE across
different target audiences [6,12,40].
The main potential limitation of the RCT is that it will
be conducted within one division of the MOHLTC, and
hence, there is the potential for contamination of study
groups despite the use of a user-specific login. Given
that many of the policy analysts and advisors work col-
laboratively, resources from the full-serve evidence ser-
vice may be shared with those who had been allocated
to the self-serve arm. Unfortunately, there is no
mechanism to protect against this fully. However, we
will adjust for variables (such as the branch in which
the policy analyst is based) that may be correlated with
degree of collaboration, and hence likelihood of contam-
ination; we will measure the number of times that
monthly email alerts are forwarded; and we will ask
about contamination in the qualitative process study.
Furthermore, if we find a significant amount of contami-
nation through the qualitative study, it suggests that the
full-serve evidence service is perceived as highly useful
by those not allocated to receive it.
Acknowledgements
The authors thank Adalsteinn Brown, Alison Paprica, and Sarah Caldwell,
MOHLTC, for supporting the study and identifying ways to allow for its
operationalisation. The authors also thank the MOHLTC for supporting the
study financially through its grant to the Centre for Health Economics and
Policy Analysis at McMaster University.
Author details
1McMaster Health Forum, Hamilton, Canada.
2Centre for Health Economics
and Policy Analysis, McMaster University, Hamilton, Canada.
3Department of
Clinical Epidemiology and Biostatistics, McMaster University, Hamilton,
Canada.
4Department of Political Science, McMaster University, Hamilton,
Canada.
5Health Research Methodology Program, McMaster University,
Hamilton, Canada.
6Clinical Epidemiology Program, Ottawa Hospital Research
Institute, Ottawa, Canada.
7Department of Medicine, University of Ottawa,
Ottawa, Canada.
8Institute of Population Health, University of Ottawa,
Ottawa, Canada.
9Health Information Research Unit, McMaster University,
Hamilton, Canada.
10School of Rehabilitation Science, McMaster University,
Hamilton, Canada.
11CanChild Centre for Childhood Disability Research,
McMaster University, Hamilton, Canada.
12Evidence-based Practice Centre,
McMaster University, Hamilton, Canada.
13The National Trauma Research
Institute, Alfred Hospital, Melbourne, Australia.
14Departments of Surgery &
Public Health, Monash University, Melbourne, Australia.
15Department of
Political Science, Université Laval, Québec, Canada.
16Centre de Recherche
du Centre Hospitalier Universitaire de Québec, Québec, Canada.
Authors’ contributions
JNL conceived of the study, participated in its design, led its planning, and
helped to draft the protocol. MGW participated in the design and planning
of the study and drafted the protocol. JMG and RBH participated in the
design of the study and provided feedback on drafts of the protocol. SH
participated in the design of the study, supported the sample-size
calculations, and provided feedback on drafts of the protocol. PR, RG, and
MO provided feedback on drafts of the protocol. All authors read and
approved the final manuscript.
Competing interests
Three of the authors (JNL, MGW, and JMG) were involved in the
development, and remain involved in the continuous updating, of Health
Systems Evidence, which is the intervention being tested in the trial.
Received: 26 November 2010 Accepted: 27 May 2011
Published: 27 May 2011
References
1. Lavis JN: How can we support the use of systematic reviews in
policymaking? PLoS Medicine 2009, 6.
2. Egger M, Smith GD, O’Rourke K: Rationale, potentials, and promise of
systematic reviews. In Systematic Reviews in Health Care: Meta-Analysis in
Context.. Second edition. Edited by: Egger M, Smith GD, Altman DG.
London: BMJ Books; 2001:3-19.
3. Lavis JN, Davies HTO, Oxman AD, Denis J-L, Golden-Biddle K, Ferlie E:
Towards systematic reviews that inform health care management and
policy-making. Journal of Health Services Research and Policy 2005, 10:
S1:35-S1:48.
4. Lavis JN, Davies HTO, Gruen RL: Working within and beyond the
Cochrane Collaboration to make systematic reviews more useful to
healthcare managers and policy makers. Healthcare Policy 2006, 1:21-33.
5. Innvaer S, Vist GE, Trommald M, Oxman AD: Health policy-makers’
perceptions of their use of evidence: A systematic review. Journal of
Health Services Research and Policy 2002, 7:239-244.
6. Haynes RB, Cotoi C, Holland J, Walters L, Wilczynski N, Jedraszewski D,
McKinlay J, Parrish R, McKibbon KA, the McMaster Premium Literature
Service (PLUS) Project: Second-Order Peer Review of the Medical
Literature for Clinical Practitioners. JAMA 2006, 295:1801-1808.
7. Lavis JN, Permanand G, Oxman AD, Lewin SA, Fretheim A: SUPPORT Tools
for evidence-informed health Policymaking (STP) 13: Preparing and
using policy briefs to support evidence-informed policymaking. Health
Research Policy and Systems 2009, 7.
8. Oxman A, Schunemann H, Fretheim A: Improving the use of research
evidence in guideline development: 8. Synthesis and presentation of
evidence. Health Research Policy and Systems 2006, 4:20.
9. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C,
Porter AC, Tugwell P, Moher D, Bouter LM: Development of AMSTAR: A
measurement tool to assess the methodological quality of systematic
reviews. BMC Medical Research Methodology 2007, 7.
10. Lavis JN, Wilson MG, Hammill AC, Boyko JA, Grimshaw J, Oxman A,
Flottorp S: Enhancing the retrieval of systematic reviews that can inform
health system management and policymaking Hamilton, Canada: Program in
Policy Decision-Making; 2009.
11. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L,
Whitty P, Eccles MP, Matowe L, Shirran L, et al: Effectiveness and efficiency
of guideline dissemination and implementation strategies. Health
Technology Assessment 2004, 8.
12. Haynes RB, Holland J, Cotoi C, McKinlay RJ, Wilczynski NL, Walters LA,
Jedras D, Parrish R, McKibbon KA, Garg A, et al: McMaster PLUS: A cluster
randomized clinical trial of an intervention to accelerate clinical use of
Lavis et al. Implementation Science 2011, 6:51
http://www.implementationscience.com/content/6/1/51
Page 7 of 8evidence-based information from digital libraries. Journal of the American
Medical Informatics Association 2006, 13:593-600.
13. Creswell JW, Plano Clark VL: Designing and Conducting Mixed Methods
Research Thousand Oaks, California: Sage; 2007.
14. Lavis JN, Ross SE, McLeod CB, Gildiner A: Measuring the impact of health
research. Journal of Health Services Research and Policy 2003, 8:165-170.
15. Lavis JN: Ideas at the margin or marginalized ideas? Nonmedical
determinants of health in Canada. Health Affairs 2002, 21:107-112.
16. Lavis JN, Ross SE, Hurley JE, Hohenadel JM, Stoddart GL, Woodward CA,
Abelson J: Examining the role of health services research in public
policymaking. Milbank Quarterly 2002, 80:125-154.
17. Lavis JN: A political science perspective on evidence-based decision-
making. In Using knowledge and evidence in health care: Multidisciplinary
perspectives. Edited by: Lemieux-Charles L, Champagne F. Toronto, Canada:
University of Toronto Press; 2004:70-85.
18. Lavis JN: Research, public policymaking, and knowledge-translation
processes: Canadian efforts to build bridges. The Journal of Continuing
Education in the Health Professions 2006, 26:37-45.
19. Foy R, MacLennan G, Grimshaw JM, Penney G, Campbell M, Grol RP:
Attributes of clinical recommendations that influence change in practice
following audit and feedback. Journal of Clinical Epidemiology 2002,
55:17-22.
20. Grilli R, Lomas J: Evaluating the message: The relationship between
compliance rate and the subject of a practice guideline. Medical Care
1994, 32:202-213.
21. Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H: Attributes of
clinical guidelines that influence use of guidelines in general practice:
Observational study. British Medical Journal 1998, 317:858-861.
22. Ajzen I: The theory of planned behaviour. Organizational Behavior and
Human Decision Processes 1991, 50:179-211.
23. Francis JJ, Eccles MP, Johnston M, Walker A, Grimshaw J, Foy R, Kaner EFS,
Smith L, Bonetti D: Constructing Questionnaires Based on the Theory of
Planned Behaviour: A Manual for Health Services Researchers Newcastle upon
Tyne, England: Centre for Health Services Research, University of Newcastle;
2004.
24. Armitage CJ, Conner M: Efficacy of the theory of planned behaviour: A
meta-analytic review. British Journal of Social Psychology 2001, 40:471-499.
25. Sheeran P: Intention-behavior relations: A conceptual and empirical
review. In European Review of Social Psychology. Edited by: Strobe W,
Hewscone M. Chichester, England: John Wiley 2002:1-36.
26. Bonetti D, Pitts NB, Eccles M, Grimshaw J, Johnston M, Steen N, Glidewell L,
Thomas R, MacLennan G, Clarkson JE, et al: Applying psychological theory
to evidence-based clinical practice: Identifying factors predictive of
taking intra-oral radiographs. Soc Sci Med 2006, 63:1889-1899.
27. Walker A, Watson M, Grimshaw J, Bond C: Applying the theory of planned
behaviour to pharmacists’ beliefs and intentions about the treatment of
vaginal candidiasis with non-prescription medicines. Family Practice 2004,
21:1-7.
28. Walker AE, Grimshaw JM, Armstrong EM: Salient beliefs and intentions to
prescribe antibiotics for patients with a sore throat. British Journal of
Health Psychology 2001, 6:347-360.
29. Eccles MP, Hrisos S, Francis J, kaner EF, Dickinson HO, Beyer F, Johnston M:
Do self-reported intentions predict clinicians’ behaviour: A systematic
review. Implementation Science 2006, 1:28.
30. Boyko JA, Lavis JN, Souza NM: Reliability of a Tool for Measuring Theory of
Planned Behaviour Constructs for use in Evaluating Research Use in
Policymaking Hamilton, Canada: McMaster University; 2010.
31. Streiner DL, Norman G: Health Measurement Scales: A Practical Guide to their
Development and Use New York, USA: Oxford University Press; 2008.
32. Collins KMT, Onwuegbuzie AJ, Jiao QG: A mixed methods investigation of
mixed methods sampling designs in social and health science research.
Journal of Mixed Methods Research 2007, 1:267-294.
33. Patton M: Qualitative Evaluation and Research Methods Beverly Hills, USA:
Sage; 1990.
34. Sandelowski M: Combining qualitative and quantitative sampling, data
collection, and analysis techniques in mixed-method studies. Research in
Nursing & Health 2000, 23:246-255.
35. Boeije H: A purposeful approach to the constant comparative methods
in the analysis of qualitative interviews. Quality & Quantity 2002,
36:391-409.
36. Creswell JW: Qualitative Inquiry and Research Design: Choosing Among Five
Traditions London, England: Sage Publications; 1998.
37. Pope C, Ziebland S, Mays N: Qualitative research in health care: Analysing
qualitative data. BMJ 2000, 320:114-116.
38. Lavis JN, Lomas J, Hamid M, Sewankambo NK: Assessing country-level
efforts to link research to action. Bulletin of the World Health Organization
2006, 84:620-628.
39. Mitton C, Adair CE, McKenzie E, Patten SB, Wayne Perry B: Knowledge
transfer and exchange: Review and synthesis of the literature. Milbank
Quarterly 2007, 85:729-768.
40. Dobbins M, Robeson P, Ciliska D, Hanna S, Cameron R, O’Mara L,
DeCorby K, Mercer S: A description of a knowledge broker role
implemented as part of a randomized controlled trial evaluating three
knowledge translation strategies. Implementation Science 2009, 4:23.
doi:10.1186/1748-5908-6-51
Cite this article as: Lavis et al.: Effects of an evidence service on health-
system policy makers’ use of research evidence: A protocol for a
randomised controlled trial. Implementation Science 2011 6:51.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lavis et al. Implementation Science 2011, 6:51
http://www.implementationscience.com/content/6/1/51
Page 8 of 8